WeVote
Log In

Bill

Bill

HB 2085

gender transition; minors; prohibitions.

57th Legislature - Second Regular Session Introduced by Lisa Fink and 5 co-sponsors

Arizona law prohibits puberty blockers, hormone therapy, and surgeries for gender transition in minors under 18, imposing medical and legal restrictions on transgender youth healthcare.

Senate Second Reading
0
WeVote Research Nonpartisan
Bill Summary · HB 2085

Legislative bill overview

HB 2085 restricts gender transition-related medical treatments and procedures for minors in Arizona. The bill prohibits healthcare providers from prescribing puberty blockers, hormone therapy, or performing surgeries for gender transition purposes on patients under 18 years old. It also includes provisions addressing parental notification and potential civil liability for providers who violate these restrictions.

Why is this important

This legislation directly affects healthcare access for transgender and gender-nonconforming youth in Arizona, impacting medical treatment options, family decision-making autonomy, and healthcare provider practices. The bill reflects broader national debates about parental rights, medical autonomy for minors, and the appropriate role of government in healthcare decisions.

Potential points of contention

  • Medical standards conflict: Major medical organizations (AMA, AAP, Endocrine Society) support age-appropriate gender-affirming care as evidence-based treatment, while bill supporters cite concerns about irreversible treatments for minors
  • Parental authority versus minor autonomy: The bill prioritizes parental involvement, but raises questions about minors' medical decision-making rights and situations involving parental abuse or rejection
  • Healthcare provider liability: Unclear liability provisions could deter providers from offering any transition-related care, potentially forcing families to seek treatment out-of-state

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.